Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
PODCAST | Deals

Building biotech ecosystems in Asia: an East-West Summit podcast

Takeaways from BioCentury’s East-West Biopharma Summit focus on Japan, India, China, plus the NewCo Model

By Jeff Cranmer, Executive Editor
March 12, 2025 12:36 AM UTC

While the culling of companies in the biotech bear market may have yet to subside, creative cross-border dealmaking on innovative assets is spreading across Asia’s Arc of Innovation. Sciwind Biosciences Co. Ltd.’s Jing Xu and A*Star’s Lisa Ooi join BioCentury to wrap up the 4th annual BioCentury-BayHelix East-West Biopharma Summit in Singapore by discussing deal-making trends, the rise of new technologies and the deepening of biotech ecosystems from India to Japan.

Xu is VP and head of global strategy for Sciwind and a veteran of global VC Lyfe Capital;
Ooi is the former COO of Hummingbird Bioscience Pte. Ltd. who is now assistant chief executive biomedical research council at Singapore’s A*Star (the Agency for Science, Technology and Research).

Purchase Reprint/Distribution Rights
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Agency for Science, Technology and Research

Lyfe Capital